Abstract:Background: This study aimed to investigate the clinical efficacy of target artery perfusion of verapamil combined with chemotherapy in treating esophageal cancer (EC).Methods: A total of 46 patients with EC (stage III and IV) were treated with verapamil combined with chemotherapy via target artery infusion. Two to four courses per month of the treatment were administrated. Imaging modalities used in staging EC before and after treatment include gastroscopy/endoscopic ultrasonography, computed tomography (CT) combined with 64-detector-row gemstone spectral imaging/3.0-T magnetic resonance imaging (MRI). The clinical beneficial rate and survival time were also evaluated.Results: Out of 46 patients, 2 cases achieved complete remission (CR) and 39 cases achieved partial remission (PR). There were 3 cases had no change and 2 cases with progressive disease. The overall effective rate (CR + PR) was 89.13%. After treatment, dysphagia in 42 patients was significantly improved except 5 cases with narrow type. A total of 11 cases with hoarseness caused by recurrent laryngeal nerve paralysis before therapy recovered normal voice and another 7 cases were completely relieved. Forty-five patients were treated with 1 course of radiotherapy, and 1 patient was treated by operation after 2 to 4 courses of treatment and clinical tumor stage had decreased. A total of 42 patients (91.30%) survived for more than a year, 24 patients (52.17%) survived for more than 2 years, and 12 patients (26.09%) survived for more than 3 years. Patients also achieved better Karnofsky performance status (KPS) scores, body weight, and positive clinical benefit of the dosage of analgesics, which were 91.30% (42/46), 52.17% (24/46), and 66.67% (4/6), respectively. No significant complication was observed before and after verapamil.Conclusions: Target artery infusion of verapamil combined with chemotherapy drug significantly reduced the clinical tumor stage of advanced EC (≥ stages III), improved the quality of life, and prolonged the survival time. And patients regained the opportunity of radical radiotherapy or surgery when the clinical tumor stages were decreased.

Investigation of Increased Efficacy of Trans-Arterial Infusion of HaHCO_3 and Verapamil on Solid Malignant Tumors in Interventional Chemotherapy

Increased Effects of Verapamil Combined with NaHCO_3 by Aterial Infusion in Patients with Solid Maligant Tumors

Investigation of Increasing Efficacy of Aterial Infusion of NaHCO3 to Solid Malignant Tumors in Interventional Chemotherapy

The Increased Effect of Partial Anti-Tumor Agents by Infusing Sodium Bicarbonate Through Target Artery

Study on Arterial Infusion of NaHCO_(3) and Verapamil to Improve Effects of Transcatheter Arterial Embolization (TAE) in Hepatocarcinoma by Color Dopple Ultrusonography

Clinical Evaluation of Targeted Arterial Infusion of Verapamil in the Interventional Chemotherapy of Primary Hepatocellular Carcinoma

Clinical Efficacy of Chemotherapy Combined with Verapamil in Metastatic Colorectal Patients

THE AFFECION ON THE TREATMENT TO HEPATIC CANCER BY INJECTION OF CHEMICALS WITH IL-2 VIA EMBEDDED SUBCUTANEOUS CHEMATHERAPUTIC PUMP

Efficacy of Chemotherapy Combined with Targeted Arterial Infusion of Verapamil in Patients with Advanced Gastric Cancer.

Evaluation of Clinical Efficacy after Combinational Treatment of Esophageal Cancer Using Target Artery Perfusion of Verapamil and Chemotherapy

Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases from Colorectal Cancer: a Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481).

Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer

Clinical Observation of Verapamil Combined with Antitumor Drugs in Treating Malignant Pleural Effusion

Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy(HAIC) Combined with PD-1 Inhibitors for Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Multicenter Propensity Score Matching Analysis

Analysis of intraperitoneal hyperthermic chemoperfusion combined with interleukin-2 in the treatment of malignant ascites

Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.

Treatment of Malignant Ascites with a Combination of Chemotherapy Drugs and Intraperitoneal Perfusion of Verapamil.

Phase Ii Randomized Study of High-Dose Interferon Alfa-2b (hdi) Versus Chemotherapy As Adjuvant Therapy in Patients with Resected Mucosal Melanoma

Monitoring Treatment Efficacy of Antiangiogenic Therapy Combined With Hypoxia-Activated Prodrugs Online Using Functional MRI

Arterial Chemotherapy of 5-Fluorouracil and Mitomycin C in the Treatment of Liver Metastases of Colorectal Cancer

Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis